These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 19210207

  • 1. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G, Palano F, Pagannone E, Chin D, Ferrucci A, Volpe M.
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [Abstract] [Full Text] [Related]

  • 2. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C, Haller H, Menne J.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [Abstract] [Full Text] [Related]

  • 3. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG, Pontremoli R.
    J Nephrol; 2011 Aug; 24(4):428-37. PubMed ID: 21279953
    [Abstract] [Full Text] [Related]

  • 4. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M, Pruijm M, Wuerzner G.
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC.
    Arzneimittelforschung; 2010 Aug; 60(3):124-30. PubMed ID: 20422943
    [Abstract] [Full Text] [Related]

  • 6. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P.
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C, Stabouli S, Kotsis V.
    Vasc Health Risk Manag; 2016 Jun; 12():443-451. PubMed ID: 27895487
    [Abstract] [Full Text] [Related]

  • 8. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
    Borghi C, Cicero AF.
    Clin Drug Investig; 2010 Jun; 30(12):843-54. PubMed ID: 20923243
    [Abstract] [Full Text] [Related]

  • 9. [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].
    Laganović M.
    Lijec Vjesn; 2010 Jun; 132(3-4):94-8. PubMed ID: 20540436
    [Abstract] [Full Text] [Related]

  • 10. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 11. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 12. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR.
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [Abstract] [Full Text] [Related]

  • 13. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME, Epstein BJ.
    J Cardiovasc Nurs; 2009 Jun; 24(5):380-9. PubMed ID: 19707098
    [Abstract] [Full Text] [Related]

  • 14. Fixed-dose combination lercanidipine/enalapril.
    Hair PI, Scott LJ, Perry CM.
    Drugs; 2007 Jun; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [Abstract] [Full Text] [Related]

  • 15. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [Abstract] [Full Text] [Related]

  • 16. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE.
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF, Gerocarni B, Rosticci M, Borghi C.
    Clin Exp Hypertens; 2012 Jan; 34(2):113-7. PubMed ID: 21967031
    [Abstract] [Full Text] [Related]

  • 18. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
    Barrios V, Escobar C, Echarri R.
    Vasc Health Risk Manag; 2008 Jan; 4(4):847-53. PubMed ID: 19066001
    [Abstract] [Full Text] [Related]

  • 19. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J.
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [Abstract] [Full Text] [Related]

  • 20. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ, Le Jeune S, Pirollo A, Mourad C, Gaudouen Y, Lopez-Sublet M.
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.